258 related articles for article (PubMed ID: 31809194)
1. A Type IV-A CRISPR-Cas System in
Crowley VM; Catching A; Taylor HN; Borges AL; Metcalf J; Bondy-Denomy J; Jackson RN
CRISPR J; 2019 Dec; 2(6):434-440. PubMed ID: 31809194
[TBL] [Abstract][Full Text] [Related]
2. Characterization and Repurposing of Type I and Type II CRISPR-Cas Systems in Bacteria.
Hidalgo-Cantabrana C; Goh YJ; Barrangou R
J Mol Biol; 2019 Jan; 431(1):21-33. PubMed ID: 30261168
[TBL] [Abstract][Full Text] [Related]
3. SnapShot: CRISPR-RNA-guided adaptive immune systems.
Carter J; Wiedenheft B
Cell; 2015 Sep; 163(1):260-260.e1. PubMed ID: 26406380
[TBL] [Abstract][Full Text] [Related]
4. Unravelling the structural and mechanistic basis of CRISPR-Cas systems.
van der Oost J; Westra ER; Jackson RN; Wiedenheft B
Nat Rev Microbiol; 2014 Jul; 12(7):479-92. PubMed ID: 24909109
[TBL] [Abstract][Full Text] [Related]
5. Requirements for Pseudomonas aeruginosa Type I-F CRISPR-Cas Adaptation Determined Using a Biofilm Enrichment Assay.
Heussler GE; Miller JL; Price CE; Collins AJ; O'Toole GA
J Bacteriol; 2016 Nov; 198(22):3080-3090. PubMed ID: 27573013
[TBL] [Abstract][Full Text] [Related]
6. Type IV CRISPR RNA processing and effector complex formation in Aromatoleum aromaticum.
Özcan A; Pausch P; Linden A; Wulf A; Schühle K; Heider J; Urlaub H; Heimerl T; Bange G; Randau L
Nat Microbiol; 2019 Jan; 4(1):89-96. PubMed ID: 30397343
[TBL] [Abstract][Full Text] [Related]
7. Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas aeruginosa.
Luz ACO; da Silva JMA; Rezende AM; de Barros MPS; Leal-Balbino TC
Mol Genet Genomics; 2019 Oct; 294(5):1095-1105. PubMed ID: 31098740
[TBL] [Abstract][Full Text] [Related]
8. Type IV CRISPR-Cas systems are highly diverse and involved in competition between plasmids.
Pinilla-Redondo R; Mayo-Muñoz D; Russel J; Garrett RA; Randau L; Sørensen SJ; Shah SA
Nucleic Acids Res; 2020 Feb; 48(4):2000-2012. PubMed ID: 31879772
[TBL] [Abstract][Full Text] [Related]
9. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
10. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
[TBL] [Abstract][Full Text] [Related]
11. Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system.
Høyland-Kroghsbo NM; Paczkowski J; Mukherjee S; Broniewski J; Westra E; Bondy-Denomy J; Bassler BL
Proc Natl Acad Sci U S A; 2017 Jan; 114(1):131-135. PubMed ID: 27849583
[TBL] [Abstract][Full Text] [Related]
12. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
13. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
14. Type III CRISPR-Cas System: Introduction And Its Application for Genetic Manipulations.
Liu T; Pan S; Li Y; Peng N; She Q
Curr Issues Mol Biol; 2018; 26():1-14. PubMed ID: 28879852
[TBL] [Abstract][Full Text] [Related]
15. RNA Guide Complementarity Prevents Self-Targeting in Type VI CRISPR Systems.
Meeske AJ; Marraffini LA
Mol Cell; 2018 Sep; 71(5):791-801.e3. PubMed ID: 30122537
[TBL] [Abstract][Full Text] [Related]
16. CRISPR-Cas systems restrict horizontal gene transfer in Pseudomonas aeruginosa.
Wheatley RM; MacLean RC
ISME J; 2021 May; 15(5):1420-1433. PubMed ID: 33349652
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Characterization of Cascade type I-E CRISPR Guide Efficacy Reveals Unexpected PAM Diversity and Target Sequence Preferences.
Fu BX; Wainberg M; Kundaje A; Fire AZ
Genetics; 2017 Aug; 206(4):1727-1738. PubMed ID: 28634160
[TBL] [Abstract][Full Text] [Related]
18. Three New Cs for CRISPR: Collateral, Communicate, Cooperate.
Varble A; Marraffini LA
Trends Genet; 2019 Jun; 35(6):446-456. PubMed ID: 31036344
[TBL] [Abstract][Full Text] [Related]
19. CRISPR control of virulence in Pseudomonas aeruginosa.
Wiedenheft B; Bondy-Denomy J
Cell Res; 2017 Feb; 27(2):163-164. PubMed ID: 28084330
[TBL] [Abstract][Full Text] [Related]
20. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
